331 related articles for article (PubMed ID: 16126355)
1. Prophylaxis approach to a-symptomatic post-menopausal women: breast cancer.
Aguas F; Martins A; Gomes TP; de Sousa M; Silva DP;
Maturitas; 2005 Nov; 52 Suppl 1():S23-31. PubMed ID: 16126355
[TBL] [Abstract][Full Text] [Related]
2. Risk-reducing strategies for breast cancer--a review of recent literature.
Mokbel K
Int J Fertil Womens Med; 2003; 48(6):274-7. PubMed ID: 15646397
[TBL] [Abstract][Full Text] [Related]
3. Risks, benefits, and effects on quality of life of selective estrogen-receptor modulator therapy in postmenopausal women at increased risk of breast cancer.
Ganz PA; Land SR
Menopause; 2008; 15(4 Suppl):797-803. PubMed ID: 18596601
[TBL] [Abstract][Full Text] [Related]
4. Risks and benefits of therapy with menopausal hormones versus selective estrogen-receptor modulators in peri- and postmenopausal women at increased breast cancer risk.
Col NF; Chlebowski RT
Menopause; 2008; 15(4 Suppl):804-9. PubMed ID: 18596602
[TBL] [Abstract][Full Text] [Related]
5. Selective estrogen receptor modulators (SERMs): mechanisms of anticarcinogenesis and drug resistance.
Lewis JS; Jordan VC
Mutat Res; 2005 Dec; 591(1-2):247-63. PubMed ID: 16083919
[TBL] [Abstract][Full Text] [Related]
6. Rationale for using raloxifene to prevent both osteoporosis and breast cancer in postmenopausal women.
Lee WL; Chao HT; Cheng MH; Wang PH
Maturitas; 2008 Jun; 60(2):92-107. PubMed ID: 18534794
[TBL] [Abstract][Full Text] [Related]
7. Recent results from clinical trials using SERMs to reduce the risk of breast cancer.
Vogel VG
Ann N Y Acad Sci; 2006 Nov; 1089():127-42. PubMed ID: 17261762
[TBL] [Abstract][Full Text] [Related]
8. 14. Breast cancer prevention.
Salih AK; Fentiman IS
Int J Clin Pract; 2002 May; 56(4):267-71. PubMed ID: 12074209
[TBL] [Abstract][Full Text] [Related]
9. [Menopause and hormone replacement therapy].
Tóth KS
Orv Hetil; 2000 Mar; 141(11):547-56. PubMed ID: 10741167
[TBL] [Abstract][Full Text] [Related]
10. Chemoprevention in postmenopausal women.
Rastogi P
Menopause; 2008; 15(4 Suppl):810-5. PubMed ID: 18596603
[TBL] [Abstract][Full Text] [Related]
11. Effect of endogenous and exogenous hormones on breast cancer: epidemiology.
Vessey MP
Verh Dtsch Ges Pathol; 1997; 81():493-501. PubMed ID: 9474890
[TBL] [Abstract][Full Text] [Related]
12. Hormonal interventions to prevent hormonal cancers: breast and prostate cancers.
Dunn BK; Ford LG
Eur J Cancer Prev; 2007 Jun; 16(3):232-42. PubMed ID: 17415094
[TBL] [Abstract][Full Text] [Related]
13. [Female sex hormones increase the risk of breast cancer].
Vatten L
Tidsskr Nor Laegeforen; 1998 Aug; 118(19):2969-74. PubMed ID: 9748837
[TBL] [Abstract][Full Text] [Related]
14. The STAR trial: evidence for raloxifene as a breast cancer risk reduction agent for postmenopausal women.
Bevers TB
J Natl Compr Canc Netw; 2007 Sep; 5(8):719-24. PubMed ID: 17927929
[TBL] [Abstract][Full Text] [Related]
15. SERMs in chemoprevention of breast cancer.
Gasco M; Argusti A; Bonanni B; Decensi A
Eur J Cancer; 2005 Sep; 41(13):1980-9. PubMed ID: 15964182
[TBL] [Abstract][Full Text] [Related]
16. The potential for aromatase inhibition in breast cancer prevention.
Lønning PE; Kragh LE; Erikstein B; Hagen A; Risberg T; Schlichting E; Geisler J
Clin Cancer Res; 2001 Dec; 7(12 Suppl):4423s-4428s; discussion 4411s-4412s. PubMed ID: 11916235
[TBL] [Abstract][Full Text] [Related]
17. Hormones and breast cancer.
ESHRE Capri Workshop Group
Hum Reprod Update; 2004; 10(4):281-93. PubMed ID: 15192054
[TBL] [Abstract][Full Text] [Related]
18. Available medical choices for the management of menopause.
Castelo-Branco C; Palacios S; Calaf J; Vázquez F; Lanchares JL
Maturitas; 2005 Nov; 52 Suppl 1():S61-70. PubMed ID: 16213114
[TBL] [Abstract][Full Text] [Related]
19. Novel concepts for the chemoprevention of breast cancer through aromatase inhibition.
Kendall A; Dowsett M
Endocr Relat Cancer; 2006 Sep; 13(3):827-37. PubMed ID: 16954432
[TBL] [Abstract][Full Text] [Related]
20. Drug insight: breast cancer prevention and tissue-targeted hormone replacement therapy.
Labrie F
Nat Clin Pract Endocrinol Metab; 2007 Aug; 3(8):584-93. PubMed ID: 17643129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
